Shareholders' Equity So, based on the above formula, the ROE for Greenfire Resources is: 5.1% = CA$38m ÷ CA$742m (Based on the trailing twelve months to September 2024). The 'return' is the yearly ...

Greenfire Resources Ltd (GFR) reports a 30% increase in production and significant debt reduction, despite challenges in meeting annual production guidance.

Greenfire Resources Ltd. ( ($GFR) ) has released its Q3 earnings. Here is a breakdown of the information Greenfire Resources ...

Nattawat Klomjit, MD, shares insights on managing IgA nephropathy and C3 glomerulopathy, including innovative drugs that target kidney inflammation and proteinuria.

The following is a summary of “Association between perioperative platelet distribution width changes and postoperative acute ...

Greenfire Resources (GFR) has released an update. Greenfire Resources reported a robust 30% increase in production for Q3 2024, attributed to a ...

Delivered consolidated production of 19,125 barrels per day ("bbls/d") in Q3 2024, an increase of 30% from 14,670 bbls/d in Q3 2023, following the initiation of Greenfire's ongoing drilling campaign ...

Greenfire Resources Ltd. (NYSE: GFR) (TSX: GFR) ("Greenfire" or the "Company"), a Calgary-based energy company focused on the production and development ...

Calcium levels decreased less with each subsequent denosumab dose among individuals with osteoporosis and advanced chronic kidney disease.

Greenfire Resources (GFR) has released an update. Greenfire Resources has announced that the Toronto Stock Exchange will defer its decision on the company’s new shareholder rights plan. Despite the ...

People with chronic kidney disease, Type 2 diabetes or both were predicted to have elevated cardiovascular disease (CVD) risk 8 to 28 years sooner than someone without those conditions, according to a ...

Greenfire Resources (NYSE:GFR – Get Free Report) and Vista Energy (NYSE:VIST – Get Free Report) are both oils/energy companies, but which is the better investment? We will compare the two businesses ...